FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134772205> ?p ?o ?g. }

• W3134772205 endingPage "4146" @default.
• W3134772205 startingPage "4142" @default.
• W3134772205 abstract "On April 10, 2020, the FDA approved selumetinib (KOSELUGO, AstraZeneca) for the treatment of pediatric patients 2 years of age and older with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas. Approval was based on demonstration of a durable overall response rate per Response Evaluation in Neurofibromatosis and Schwannomatosis criteria and supported by observed clinical improvements in plexiform neurofibroma-related symptoms and functional impairments in 50 pediatric patients with inoperable plexiform neurofibromas in a single-arm, multicenter trial. The overall reponse rate per NCI investigator assessment was 66% (95% confidence interval, 51-79) with at least 12 months of follow-up. The median duration of response was not reached, and 82% of responding patients experienced duration of response ≥12 months. Clinical outcome assessment endpoints provided supportive efficacy data. Risks of selumetinib are consistent with MAPK (MEK) inhibitor class effects, including ocular, cardiac, musculoskeletal, gastrointestinal, and dermatologic toxicities. Safety was assessed across a pooled database of 74 pediatric patients with plexiform neurofibromas and supported by adult and pediatric selumetinib clinical trial data in cancer indications. The benefit-risk assessment for selumetinib in patients with inoperable plexiform neurofibromas was considered favorable." @default.
• W3134772205 created "2021-03-15" @default.
• W3134772205 creator A5004151500 @default.
• W3134772205 creator A5004658590 @default.
• W3134772205 creator A5012417328 @default.
• W3134772205 creator A5013196129 @default.
• W3134772205 creator A5015703576 @default.
• W3134772205 creator A5016881573 @default.
• W3134772205 creator A5019914745 @default.
• W3134772205 creator A5022716148 @default.
• W3134772205 creator A5030247856 @default.
• W3134772205 creator A5035436218 @default.
• W3134772205 creator A5035886806 @default.
• W3134772205 creator A5041458996 @default.
• W3134772205 creator A5045680939 @default.
• W3134772205 creator A5046208962 @default.
• W3134772205 creator A5051520990 @default.
• W3134772205 creator A5057465629 @default.
• W3134772205 creator A5063699009 @default.
• W3134772205 creator A5065397717 @default.
• W3134772205 creator A5069297078 @default.
• W3134772205 creator A5069834954 @default.
• W3134772205 creator A5070024717 @default.
• W3134772205 creator A5070924546 @default.
• W3134772205 creator A5072154348 @default.
• W3134772205 creator A5074097054 @default.
• W3134772205 creator A5075349449 @default.
• W3134772205 creator A5076769955 @default.
• W3134772205 creator A5079101201 @default.
• W3134772205 creator A5086463124 @default.
• W3134772205 date "2021-03-12" @default.
• W3134772205 modified "2023-10-16" @default.
• W3134772205 title "FDA Approval Summary: Selumetinib for Plexiform Neurofibroma" @default.
• W3134772205 cites W1848470479 @default.
• W3134772205 cites W1972615559 @default.
• W3134772205 cites W1987956240 @default.
• W3134772205 cites W2017569500 @default.
• W3134772205 cites W2022971724 @default.
• W3134772205 cites W2029394434 @default.
• W3134772205 cites W2044090623 @default.
• W3134772205 cites W2056866789 @default.
• W3134772205 cites W2127650955 @default.
• W3134772205 cites W2138616826 @default.
• W3134772205 cites W2159096148 @default.
• W3134772205 cites W2164992866 @default.
• W3134772205 cites W2297307916 @default.
• W3134772205 cites W2567378356 @default.
• W3134772205 cites W2591172233 @default.
• W3134772205 cites W2614470022 @default.
• W3134772205 cites W2802657576 @default.
• W3134772205 cites W3008678845 @default.
• W3134772205 cites W3016227349 @default.
• W3134772205 cites W4254962459 @default.
• W3134772205 doi "https://doi.org/10.1158/1078-0432.ccr-20-5032" @default.
• W3134772205 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33712511" @default.
• W3134772205 hasPublicationYear "2021" @default.
• W3134772205 type Work @default.
• W3134772205 sameAs 3134772205 @default.
• W3134772205 citedByCount "30" @default.
• W3134772205 countsByYear W31347722052021 @default.
• W3134772205 countsByYear W31347722052022 @default.
• W3134772205 countsByYear W31347722052023 @default.
• W3134772205 crossrefType "journal-article" @default.
• W3134772205 hasAuthorship W3134772205A5004151500 @default.
• W3134772205 hasAuthorship W3134772205A5004658590 @default.
• W3134772205 hasAuthorship W3134772205A5012417328 @default.
• W3134772205 hasAuthorship W3134772205A5013196129 @default.
• W3134772205 hasAuthorship W3134772205A5015703576 @default.
• W3134772205 hasAuthorship W3134772205A5016881573 @default.
• W3134772205 hasAuthorship W3134772205A5019914745 @default.
• W3134772205 hasAuthorship W3134772205A5022716148 @default.
• W3134772205 hasAuthorship W3134772205A5030247856 @default.
• W3134772205 hasAuthorship W3134772205A5035436218 @default.
• W3134772205 hasAuthorship W3134772205A5035886806 @default.
• W3134772205 hasAuthorship W3134772205A5041458996 @default.
• W3134772205 hasAuthorship W3134772205A5045680939 @default.
• W3134772205 hasAuthorship W3134772205A5046208962 @default.
• W3134772205 hasAuthorship W3134772205A5051520990 @default.
• W3134772205 hasAuthorship W3134772205A5057465629 @default.
• W3134772205 hasAuthorship W3134772205A5063699009 @default.
• W3134772205 hasAuthorship W3134772205A5065397717 @default.
• W3134772205 hasAuthorship W3134772205A5069297078 @default.
• W3134772205 hasAuthorship W3134772205A5069834954 @default.
• W3134772205 hasAuthorship W3134772205A5070024717 @default.
• W3134772205 hasAuthorship W3134772205A5070924546 @default.
• W3134772205 hasAuthorship W3134772205A5072154348 @default.
• W3134772205 hasAuthorship W3134772205A5074097054 @default.
• W3134772205 hasAuthorship W3134772205A5075349449 @default.
• W3134772205 hasAuthorship W3134772205A5076769955 @default.
• W3134772205 hasAuthorship W3134772205A5079101201 @default.
• W3134772205 hasAuthorship W3134772205A5086463124 @default.
• W3134772205 hasConcept C121608353 @default.
• W3134772205 hasConcept C126322002 @default.
• W3134772205 hasConcept C141071460 @default.
• W3134772205 hasConcept C142724271 @default.
• W3134772205 hasConcept C2776087337 @default.
• W3134772205 hasConcept C2777831590 @default.
• W3134772205 hasConcept C2778984943 @default.

• next